Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2015 (2015), Article ID 313021, 11 pages
http://dx.doi.org/10.1155/2015/313021
Review Article

The Protective Effect of Lipoic Acid on Selected Cardiovascular Diseases Caused by Age-Related Oxidative Stress

1Department of Applied Pharmacy, Department of Pharmacy, Medical University of Lodz, Muszynskiego 1, 90-151 Lodz, Poland
2Department of Cardiovascular Physiology, Medical University of Lodz, Mazowiecka 6/8, 92-215 Lodz, Poland

Received 11 December 2014; Revised 16 March 2015; Accepted 25 March 2015

Academic Editor: Ersin Fadillioglu

Copyright © 2015 Beata Skibska and Anna Goraca. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. M. Paravicini and R. M. Touyz, “NADPH oxidases, reactive oxygen species, and hypertension: clinical implications and therapeutic possibilities,” Diabetes care, vol. 31, no. 2, pp. 170–180, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Karavidas, G. Lazaros, D. Tsiachris, and V. Pyrgakis, “Aging and the cardiovascular system,” Hellenic Journal of Cardiology, vol. 51, no. 5, pp. 421–427, 2010. View at Google Scholar · View at Scopus
  3. Y. Mei, M. D. Thompson, R. A. Cohen, and X. Tong, “Autophagy and oxidative stress in cardiovascular diseases,” Biochimica et Biophysica Acta, vol. 1852, no. 2, pp. 243–251, 2015. View at Publisher · View at Google Scholar
  4. D. Harman, “Aging: a theory based on free radical and radiation chemistry,” Journal of Gerontology, vol. 11, no. 3, pp. 298–300, 1956. View at Publisher · View at Google Scholar · View at Scopus
  5. G. Bartosz, “Reactive oxygen species: destroyers or messengers?” Biochemical Pharmacology, vol. 77, no. 8, pp. 1303–1315, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. L. J. Reed, “The chemistry and function of lipoic acid,” Advances in Enzymology and Related Subjects of Biochemistry, vol. 18, pp. 319–347, 1957. View at Google Scholar · View at Scopus
  7. M. Dudek, A. Bilska-Wilkosz, J. Knutelska et al., “Are anti-inflammatory properties of lipoic acid associated with the formation of hydrogen sulfide?” Pharmacological Reports, vol. 65, no. 4, pp. 1018–1024, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. L. Packer, E. H. Witt, and H. J. Tritschler, “Alpha-lipoic acid as a biological antioxidant,” Free Radical Biology and Medicine, vol. 19, no. 2, pp. 227–250, 1995. View at Publisher · View at Google Scholar · View at Scopus
  9. F. Navari-Izzo, M. F. Quartacci, and C. Sgherri, “Lipoic acid: a unique antioxidant in the detoxification of activated oxygen species,” Plant Physiology and Biochemistry, vol. 40, no. 6–8, pp. 463–470, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Ghibu, C. Richard, C. Vergely, M. Zeller, Y. Cottin, and L. Rochette, “Antioxidant properties of an endogenous thiol: alpha-lipoic acid, useful in the prevention of cardiovascular diseases,” Journal of Cardiovascular Pharmacology, vol. 54, no. 5, pp. 391–398, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. L. Rochette, S. Ghibu, C. Richard, M. Zeller, Y. Cottin, and C. Vergely, “Direct and indirect antioxidant properties of α-lipoic acid and therapeutic potential,” Molecular Nutrition and Food Research, vol. 57, no. 1, pp. 114–125, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Bilska and L. Włodek, “Lipoic acid—the drug of the future?” Pharmacological Reports, vol. 57, no. 5, pp. 570–577, 2005. View at Google Scholar · View at Scopus
  13. C. Steyers and F. Miller, “Endothelial dysfunction in chronic inflammatory diseases,” International Journal of Molecular Sciences, vol. 15, no. 7, pp. 11324–11349, 2014. View at Publisher · View at Google Scholar
  14. N. R. Madamanchi and M. S. Runge, “Redox signaling in cardiovascular health and disease,” Free Radical Biology and Medicine, vol. 61, pp. 473–501, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. M. E. Rubio-Ruiz, I. Pérez-Torres, M. E. Soto, G. Pastelín, and V. Guarner-Lans, “Aging in blood vessels. Medicinal agents FOR systemic arterial hypertension in the elderly,” Ageing Research Reviews, vol. 18, pp. 132–147, 2014. View at Publisher · View at Google Scholar
  16. M. Monti, R. Solito, L. Puccetti et al., “Protective effects of novel metal-nonoates on the cellular components of the vascular system,” Journal of Pharmacology and Experimental Therapeutics, vol. 351, no. 3, pp. 500–509, 2014. View at Publisher · View at Google Scholar
  17. M. El Assar, J. Angulo, S. Vallejo, C. Peiró, C. F. Sánchez-Ferrer, and L. Rodríguez-Mañas, “Mechanisms involved in the aging-induced vascular dysfunction,” Frontiers in Physiology, vol. 3, article 132, Article ID Article 132, pp. 1–13, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. R. Oakley and B. Tharakan, “Vascular hyperpermeability and aging,” Aging and Disease, vol. 5, no. 2, pp. 114–125, 2014. View at Publisher · View at Google Scholar
  19. A. Csiszar, Z. Ungvari, J. G. Edwards et al., “Aging-induced phenotypic changes and oxidative stress impair coronary arteriolar function,” Circulation Research, vol. 90, no. 11, pp. 1159–1166, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. P. Pacher, J. S. Beckman, and L. Liaudet, “Nitric oxide and peroxynitrite in health and disease,” Physiological Reviews, vol. 87, no. 1, pp. 315–424, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. Zhang, S. Zhao, Y. Gu, D. F. Lewis, J. S. Alexander, and Y. Wang, “Effects of peroxynitrite and superoxide radicals on endothelial monolayer permeability: potential role of peroxynitrite in preeclampsia,” Journal of the Society for Gynecologic Investigation, vol. 12, no. 8, pp. 586–592, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. H. J. Yoon, S. W. Cho, B. W. Ahn, and S. Y. Yang, “Alterations in the activity and expression of endothelial NO synthase in aged human endothelial cells,” Mechanisms of Ageing and Development, vol. 131, no. 2, pp. 119–123, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Csiszar, Z. Ungvari, A. Koller, J. G. Edwards, and G. Kaley, “Proinflammatory phenotype of coronary arteries promotes endothelial apoptosis in aging,” Physiological Genomics, vol. 17, pp. 21–30, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Csiszar, N. Labinskyy, Z. Orosz, Z. Xiangmin, R. Buffenstein, and Z. Ungvari, “Vascular aging in the longest-living rodent, the naked mole rat,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 293, no. 2, pp. H919–H927, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Csiszar, M. Wang, E. G. Lakatta, and Z. Ungvari, “Inflammation and endothelial dysfunction during aging: role of NF-kappaB,” Journal of Applied Physiology, vol. 105, no. 4, pp. 1333–1341, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. H. Cai and D. G. Harrison, “Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress,” Circulation Research, vol. 87, no. 10, pp. 840–844, 2000. View at Publisher · View at Google Scholar · View at Scopus
  27. Y. Saito, M. Kurabayashi, T. Nakamura, and R. Nagai, “Klotho gene and endothelial function,” Nihon Ronen Igakkai Zasshi, vol. 43, no. 3, pp. 342–344, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. V. Cavieres, K. Valdes, B. Moreno, R. Moore-Carrasco, and D. R. Gonzalez, “Vascular hypercontractility and endothelial dysfunction before development of atherosclerosis in moderate dyslipidemia: role for nitric oxide and interleukin-6,” American Journal of Cardiovascular Disease, vol. 4, no. 3, pp. 114–122, 2014. View at Google Scholar
  29. G. M. Chisolm and D. Steinberg, “The oxidative modification hypothesis of atherogenesis: an overview,” Free Radical Biology and Medicine, vol. 28, no. 12, pp. 1815–1826, 2000. View at Publisher · View at Google Scholar · View at Scopus
  30. H. Mangge, K. Becker, D. Fuchs, and J. M. Gostner, “Antioxidants, inflammation and cardiovascular disease,” World Journal of Cardiology, vol. 6, no. 6, pp. 462–477, 2014. View at Publisher · View at Google Scholar
  31. C. Meisinger, J. Baumert, N. Khuseyinova, H. Loewel, and W. Koenig, “Plasma oxidized low-density lipoprotein, a strong predictor for acute coronary heart disease events in apparently healthy, middle-aged men from the general population,” Circulation, vol. 112, no. 5, pp. 651–657, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. A. H. Sprague and R. A. Khalil, “Inflammatory cytokines in vascular dysfunction and vascular disease,” Biochemical Pharmacology, vol. 78, no. 6, pp. 539–552, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. A. R. Weseler and A. Bast, “Oxidative stress and vascular function: implications for pharmacologic treatments,” Current Hypertension Reports, vol. 12, no. 3, pp. 154–161, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. T. Watson, P. K. Y. Goon, and G. Y. H. Lip, “Endothelial progenitor cells, endothelial dysfunction, inflammation, and oxidative stress in hypertension,” Antioxidants and Redox Signaling, vol. 10, no. 6, pp. 1079–1088, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. M. D. Herrera, C. Mingorance, R. Rodríguez-Rodríguez, and M. Alvarez de Sotomayor, “Endothelial dysfunction and aging: an update,” Ageing Research Reviews, vol. 9, no. 2, pp. 142–152, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Kajiya, M. Hirota, Y. Inai et al., “Impaired NO-mediated vasodilation with increased superoxide but robust EDHF function in right ventricular arterial microvessels of pulmonary hypertensive rats,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 292, no. 6, pp. H2737–H2744, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. A. Piechota, A. Polańczyk, and A. Goraca, “Role of endothelin-1 receptor blockers on hemodynamic parameters and oxidative stress,” Pharmacological Reports, vol. 62, no. 1, pp. 28–34, 2010. View at Google Scholar · View at Scopus
  38. D. Versari, E. Daghini, A. Virdis, L. Ghiadoni, and S. Taddei, “Endothelium-dependent contractions and endothelial dysfunction in human hypertension,” British Journal of Pharmacology, vol. 157, no. 4, pp. 527–536, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. A. Kowalczyk, P. Kleniewska, M. Kolodziejczyk, B. Skibska, and A. Goraca, “The role of endothelin-1 and endothelin receptor antagonists in inflammatory response and sepsis,” Archivum Immunologiae et Therapiae Experimentalis, vol. 63, no. 1, pp. 41–52, 2015. View at Publisher · View at Google Scholar
  40. T. Kumazaki, “Modulation of gene expression during aging of human vascular endothelial cells,” Hiroshima Journal of Medical Sciences, vol. 42, no. 2, pp. 97–100, 1993. View at Google Scholar · View at Scopus
  41. R. P. Brandes, I. Fleming, and R. Busse, “Endothelial aging,” Cardiovascular Research, vol. 66, no. 2, pp. 286–294, 2005. View at Publisher · View at Google Scholar · View at Scopus
  42. T. G. Canty Jr., E. M. Boyle Jr., A. Farr, E. N. Morgan, E. D. Verrier, and T. H. Pohlman, “Oxidative stress induces NF-κB nuclear translocation without degradation of IκBα,” Circulation, vol. 100, no. 19, pp. 361–364, 1999. View at Publisher · View at Google Scholar · View at Scopus
  43. P. Kleniewska, A. Piechota-Polanczyk, L. Michalski et al., “Influence of block of NF-kappa B signaling pathway on oxidative stress in the liver homogenates,” Oxidative Medicine and Cellular Longevity, vol. 2013, Article ID 308358, 8 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  44. S. R. Bhatt, M. F. Lokhandwala, and A. A. Banday, “Vascular oxidative stress upregulates angiotensin II type I receptors via mechanisms involving nuclear factor kappa B,” Clinical and Experimental Hypertension, vol. 36, no. 6, pp. 367–373, 2014. View at Publisher · View at Google Scholar
  45. D. Versari, E. Daghini, A. Virdis, L. Ghiadoni, and S. Taddei, “Endothelial dysfunction as a target for prevention of cardiovascular disease,” Diabetes Care, vol. 32, no. 2, pp. 314–321, 2009. View at Publisher · View at Google Scholar · View at Scopus
  46. O. Yildiz, “Vascular smooth muscle and endothelial functions in aging,” Annals of the New York Academy of Sciences, vol. 1100, pp. 353–360, 2007. View at Publisher · View at Google Scholar · View at Scopus
  47. D. E. Kohan, E. W. Inscho, D. Wesson, and D. M. Pollock, “Physiology of endothelin and the kidney,” Comprehensive Physiology, vol. 1, no. 2, pp. 883–919, 2011. View at Publisher · View at Google Scholar · View at Scopus
  48. G. R. Drummond, S. Selemidis, K. K. Griendling, and C. G. Sobey, “Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets,” Nature Reviews Drug Discovery, vol. 10, no. 6, pp. 453–471, 2011. View at Publisher · View at Google Scholar · View at Scopus
  49. P. N. Seshiah, D. S. Weber, P. Rocic, L. Valppu, Y. Taniyama, and K. K. Griendling, “Angiotensin II stimulation of NAD(P)H oxidase activity: upstream mediators,” Circulation Research, vol. 91, no. 5, pp. 406–413, 2002. View at Publisher · View at Google Scholar · View at Scopus
  50. T. M. Paravicini, S. Chrissobolis, G. R. Drummond, and C. G. Sobey, “Increased NADPH-oxidase activity and Nox4 expression during chronic hypertension is associated with enhanced cerebral vasodilatation to NADPH in vivo,” Stroke, vol. 35, no. 2, pp. 584–589, 2004. View at Publisher · View at Google Scholar · View at Scopus
  51. R. M. Touyz, “Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension. What is the clinical significance?” Hypertension, vol. 44, no. 3, pp. 248–252, 2004. View at Publisher · View at Google Scholar · View at Scopus
  52. Q. N. Dinh, G. R. Drummond, C. G. Sobey, and S. Chrissobolis, “Roles of inflammation, oxidative stress, and vascular dysfunction in hypertension,” BioMed Research International, vol. 2014, pp. 1–11, 2014. View at Publisher · View at Google Scholar
  53. M. M. Govender and A. Nadar, “A subpressor dose of angiotensin II elevates blood pressure in a normotensive rat model by oxidative stress,” Physiological Research. In press.
  54. M. P. Ocaranza, J. Moya, V. Barrientos et al., “Angiotensin-(1-9) reverses experimental hypertension and cardiovascular damage by inhibition of the angiotensin converting enzyme/Ang II axis,” Journal of Hypertension, vol. 32, no. 4, pp. 771–783, 2014. View at Publisher · View at Google Scholar · View at Scopus
  55. S.-J. Lee and S.-H. Park, “Arterial ageing,” Korean Circulation Journal, vol. 43, no. 2, pp. 73–79, 2013. View at Publisher · View at Google Scholar · View at Scopus
  56. M. Pacurari, R. Kafoury, P. B. Tchounwou, and K. Ndebele, “The renin-angiotensin-aldosterone system in vascular inflammation and remodeling,” International Journal of Inflammation, vol. 2014, Article ID 689360, 13 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  57. D. F. Dai, Y. A. Chiao, D. J. Marcinek, H. H. Szeto, and P. S. Rabinovitch, “Mitochondrial oxidative stress in aging and healthspan,” Longevity & Healthspan, vol. 3, article 6, 2014. View at Publisher · View at Google Scholar
  58. E. J. Lesnefsky, S. Moghaddas, B. Tandler, J. Kerner, and C. L. Hoppel, “Mitochondrial dysfunction in cardiac disease: ischemia—reperfusion, aging, and heart failure,” Journal of Molecular and Cellular Cardiology, vol. 33, no. 6, pp. 1065–1089, 2001. View at Publisher · View at Google Scholar · View at Scopus
  59. S. Pepe, “Mitochondrial function in ischaemia and reperfusion of the ageing heart,” Clinical and Experimental Pharmacology and Physiology, vol. 27, no. 9, pp. 745–750, 2000. View at Publisher · View at Google Scholar · View at Scopus
  60. S. Khurana, K. Venkataraman, A. Hollingsworth, M. Piche, and T. C. Tai, “Polyphenols: benefits to the cardiovascular system in health and in aging,” Nutrients, vol. 5, no. 10, pp. 3779–3827, 2013. View at Publisher · View at Google Scholar · View at Scopus
  61. T. Yamamoto and J. Sadoshima, “Protection of the heart against ischemia/reperfusion by silent information regulator 1,” Trends in Cardiovascular Medicine, vol. 21, no. 1, pp. 27–32, 2011. View at Publisher · View at Google Scholar · View at Scopus
  62. A. Jahangir, S. Sagar, and A. Terzic, “Aging and cardioprotection,” Journal of Applied Physiology, vol. 103, no. 6, pp. 2120–2128, 2007. View at Publisher · View at Google Scholar · View at Scopus
  63. F. Di Lisa and P. Bernardi, “Mitochondrial function and myocardial aging. A critical analysis of the role of permeability transition,” Cardiovascular Research, vol. 66, no. 2, pp. 222–232, 2005. View at Publisher · View at Google Scholar · View at Scopus
  64. M. Avkiran and M. S. Marber, “Na+/H+ exchange inhibitors for cardioprotective therapy: progress, problems and prospects,” Journal of the American College of Cardiology, vol. 39, no. 5, pp. 747–753, 2002. View at Publisher · View at Google Scholar · View at Scopus
  65. N. Gonzaga, G. E. Callera, A. Yogi et al., “Acute ethanol intake induces mitogen-activated protein kinase activation, platelet-derived growth factor receptor phosphorylation, and oxidative stress in resistance arteries,” Journal of Physiology and Biochemistry, vol. 70, no. 2, pp. 509–523, 2014. View at Publisher · View at Google Scholar · View at Scopus
  66. T. Finkel and N. J. Holbrook, “Oxidants, oxidative stress and the biology of ageing,” Nature, vol. 408, no. 6809, pp. 239–247, 2000. View at Publisher · View at Google Scholar · View at Scopus
  67. R. Rodrigo, M. Libuy, F. Feliú, and D. Hasson, “Oxidative stress-related biomarkers in essential hypertension and ischemia-reperfusion myocardial damage,” Disease Markers, vol. 35, no. 6, pp. 773–790, 2013. View at Publisher · View at Google Scholar · View at Scopus
  68. P. Ferdinandy, R. Schulz, and G. F. Baxter, “Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning,” Pharmacological Reviews, vol. 59, no. 4, pp. 418–458, 2007. View at Publisher · View at Google Scholar · View at Scopus
  69. S. K. Maulik and S. Kumar, “Oxidative stress and cardiac hypertrophy: a review,” Toxicology Mechanisms and Methods, vol. 22, no. 5, pp. 359–366, 2012. View at Publisher · View at Google Scholar · View at Scopus
  70. T. A. Ajith, “Mitochondria-targeted agents: fture perspectives of mitochondrial pharmaceutics in cardiovascular diseases,” World Journal of Cardiology, vol. 6, no. 10, pp. 1091–1099, 2014. View at Publisher · View at Google Scholar
  71. S. Zhou, W. Sun, Z. Zhang, and Y. Zheng, “The role of Nrf2-mediated pathway in cardiac remodeling and heart failure,” Oxidative Medicine and Cellular Longevity, vol. 2014, Article ID 260429, 16 pages, 2014. View at Publisher · View at Google Scholar
  72. T. Doenst, T. D. Nguyen, and E. D. Abel, “Cardiac metabolism in heart failure: implications beyond atp production,” Circulation Research, vol. 113, no. 6, pp. 709–724, 2013. View at Publisher · View at Google Scholar · View at Scopus
  73. V. A. Cameron, T. J. Mocatta, A. P. Pilbrow et al., “Angiotensin type-1 receptor A1166C gene polymorphism correlates with oxidative stress levels in human heart failure,” Hypertension, vol. 47, no. 6, pp. 1155–1161, 2006. View at Publisher · View at Google Scholar · View at Scopus
  74. C. Wojciechowska, E. Romuk, A. Tomasik et al., “Oxidative stress markers and C-reactive protein are related to severity of heart failure in patients with dilated cardiomyopathy,” Mediators of Inflammation, vol. 2014, Article ID 147040, 10 pages, 2014. View at Publisher · View at Google Scholar
  75. B. Douglas and M. D. Sawyer, “Oxidative stress in heart failure: what are we missing?” American Journal of the Medical Sciences, vol. 342, no. 2, pp. 120–124, 2011. View at Publisher · View at Google Scholar · View at Scopus
  76. M. M. Elahi, Y. X. Kong, and B. M. Matata, “Oxidative stress as a mediator of cardiovascular disease,” Oxidative Medicine and Cellular Longevity, vol. 2, no. 5, pp. 259–269, 2009. View at Publisher · View at Google Scholar · View at Scopus
  77. K. Venkataraman, S. Khurana, and T. C. Tai, “Oxidative stress in aging-matters of the heart and mind,” International Journal of Molecular Sciences, vol. 14, no. 9, pp. 17897–17925, 2013. View at Publisher · View at Google Scholar · View at Scopus
  78. J. Peng, B. Liu, Q. L. Ma, and X. J. Luo, “Dysfunctional endothelial progenitor cells in cardiovascular diseases: role of NADPH oxidase,” Journal of Cardiovascular Pharmacology, vol. 65, no. 1, pp. 80–87, 2015. View at Publisher · View at Google Scholar
  79. A. D. Hafstad, A. A. Nabeebaccus, and A. M. Shah, “Novel aspects of ROS signalling in heart failure,” Basic Research in Cardiology, vol. 108, no. 4, article 359, 2013. View at Publisher · View at Google Scholar · View at Scopus
  80. A. Gora̧ca, H. Huk-Kolega, A. Piechota, P. Kleniewska, E. Ciejka, and B. Skibska, “Lipoic acid—biological activity and therapeutic potential,” Pharmacological Reports, vol. 63, no. 4, pp. 849–858, 2011. View at Publisher · View at Google Scholar · View at Scopus
  81. G. K. Glantzounis, W. Yang, R. S. Koti, D. P. Mikhailidis, A. M. Seifalian, and B. R. Davidson, “The role of thiols in liver ischemia-reperfusion injury,” Current Pharmaceutical Design, vol. 12, no. 23, pp. 2891–2901, 2006. View at Publisher · View at Google Scholar · View at Scopus
  82. U. Singh and I. Jialal, “Alpha-lipoic acid supplementation and diabetes,” Nutrition Reviews, vol. 66, no. 11, pp. 646–657, 2008. View at Publisher · View at Google Scholar · View at Scopus
  83. A. Segall, M. Sosa, A. Alami et al., “Stability study of lipoic acid in the presence of vitamins A and E in o/w emulsions for cosmetic application,” Journal of Cosmetic Science, vol. 55, no. 5, pp. 449–461, 2004. View at Google Scholar · View at Scopus
  84. S. D. Wollin and P. J. H. Jones, “Alpha-lipoic acid and cardiovascular disease,” Journal of Nutrition, vol. 133, no. 11, pp. 3327–3330, 2003. View at Google Scholar · View at Scopus
  85. A. L. Catapano, F. M. Maggi, and E. Tragni, “Low density lipoprotein oxidation, antioxidants, and atherosclerosis,” Current Opinion in Cardiology, vol. 15, no. 5, pp. 355–363, 2000. View at Publisher · View at Google Scholar · View at Scopus
  86. I. Sadowska-Bartosz and G. Bartosz, “Effect of antioxidants supplementation on aging and longevity,” BioMed Research International, vol. 2014, Article ID 404680, 17 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  87. S. Sola, M. Q. S. Mir, F. A. Cheema et al., “Irbesartan and lipoic acid improve endothelial function and reduce markers of inflammation in the metabolic syndrome: results of the Irbesartan and Lipoic Acid in Endothelial Dysfunction (ISLAND) study,” Circulation, vol. 111, no. 3, pp. 343–348, 2005. View at Publisher · View at Google Scholar · View at Scopus
  88. L. Packer, K. Kraemer, and G. Rimbach, “Molecular aspects of lipoic acid in the prevention of diabetes complications,” Nutrition, vol. 17, no. 10, pp. 888–895, 2001. View at Publisher · View at Google Scholar · View at Scopus
  89. T. C. Rideout, B. Carrier, S. Wen, A. Raslawsky, R. W. Browne, and S. V. Harding, “Complementary cholesterol-lowering response of a phytosterol/alpha-Lipoic acid combination in obese zucker rats,” Journal of Dietary Supplements, 2015. View at Publisher · View at Google Scholar
  90. D. C. Kim, D. W. Jun, E. C. Jang et al., “Lipoic acid prevents the changes of intracellular lipid partitioning by free fatty acid,” Gut and Liver, vol. 7, no. 2, pp. 221–227, 2013. View at Publisher · View at Google Scholar · View at Scopus
  91. B. Carrier, S. Wen, S. Zigouras et al., “Alpha-lipoic acid reduces LDL-particle number and PCSK9 concentrations in high-fat fed obese zucker rats,” PLoS ONE, vol. 9, no. 3, Article ID e90863, 2014. View at Publisher · View at Google Scholar · View at Scopus
  92. Y. Zhang, P. Han, N. Wu et al., “Amelioration of lipid abnormalities by α-lipoic acid through antioxidative and anti-inflammatory effects,” Obesity, vol. 19, no. 8, pp. 1647–1653, 2011. View at Publisher · View at Google Scholar · View at Scopus
  93. Z. Ying, N. Kherada, B. Farrar et al., “Lipoic acid effects on established atherosclerosis,” Life Sciences, vol. 86, no. 3-4, pp. 95–102, 2010. View at Publisher · View at Google Scholar · View at Scopus
  94. S. V. Harding, T. C. Rideout, and P. J. H. Jones, “Evidence for using alpha-lipoic acid in reducing lipoprotein and inflammatory related atherosclerotic risk,” Journal of Dietary Supplements, vol. 9, no. 2, pp. 116–127, 2012. View at Publisher · View at Google Scholar · View at Scopus
  95. W.-J. Zhang, K. E. Bird, T. S. McMillen, R. C. LeBoeuf, T. M. Hagen, and B. Frei, “Dietary α-lipoic acid supplementation inhibits atherosclerotic lesion development in apolipoprotein E-deficient and apolipoprotein E/low-density lipoprotein receptor-deficient mice,” Circulation, vol. 117, no. 3, pp. 421–428, 2008. View at Publisher · View at Google Scholar · View at Scopus
  96. Z. Amom, Z. Zakaria, J. Mohamed et al., “Lipid lowering effect of antioxidant alpha-lipoic acid in experimental atherosclerosis,” Journal of Clinical Biochemistry and Nutrition, vol. 43, no. 2, pp. 88–94, 2008. View at Publisher · View at Google Scholar · View at Scopus
  97. S. Vasdev, J. Stuckless, and V. Richardson, “Role of the immune system in hypertension: modulation by dietary antioxidants,” International Journal of Angiology, vol. 20, no. 4, pp. 189–212, 2011. View at Publisher · View at Google Scholar · View at Scopus
  98. J. Leong, S. Pepe, J. Van der Merwe et al., “Preoperative metabolic therapy improves cardiac surgical outcomes: a prospective randomized clinical trial,” Heart, Lung and Circulation, vol. 16, supplement 2, p. S178, 2007. View at Publisher · View at Google Scholar
  99. S. R. Lee, M. H. Jeong, S. Y. Lim et al., “The effect of alpha lipoic acid (Thioctacid HR) on endothelial function in diabetic and hypertensive patients,” Korean Circulation Journal, vol. 36, no. 8, pp. 559–564, 2006. View at Publisher · View at Google Scholar · View at Scopus
  100. M. Takaoka, Y. Kobayashi, M. Yuba, M. Ohkita, and Y. Matsumura, “Effects of α-lipoic acid on deoxycorticosterone acetate-salt-induced hypertension in rats,” European Journal of Pharmacology, vol. 424, no. 2, pp. 121–129, 2001. View at Publisher · View at Google Scholar · View at Scopus
  101. T. Heitzer, B. Finckh, S. Albers, K. Krohn, A. Kohlschütter, and T. Meinertz, “Beneficial effects of α-lipoic acid and ascorbic acid on endothelium-dependent, nitric oxide-mediated vasodilation in diabetic patients: relation to parameters of oxidative stress,” Free Radical Biology and Medicine, vol. 31, no. 1, pp. 53–61, 2001. View at Publisher · View at Google Scholar · View at Scopus
  102. C. M. Sena, E. Nunes, T. Louro et al., “Effects of α-lipoic acid on endothelial function in aged diabetic and high-fat fed rats,” British Journal of Pharmacology, vol. 153, no. 5, pp. 894–906, 2008. View at Publisher · View at Google Scholar · View at Scopus
  103. W.-J. Zhang and B. Frei, “α-Lipoic acid inhibits TNF-α-induced NF-κB activation and adhesion molecule expression in human aortic endothelial cells,” The FASEB Journal, vol. 15, no. 13, pp. 2423–2432, 2001. View at Publisher · View at Google Scholar · View at Scopus
  104. M. B. Gomes and C. A. Negrato, “Alpha-lipoic acid as a pleiotropic compound with potential therapeutic use in diabetes and other chronic diseases,” Diabetology & Metabolic Syndrome, vol. 6, no. 1, p. 80, 2014. View at Publisher · View at Google Scholar
  105. S. Vasdev, C. A. Ford, S. Parai, L. Longerich, and V. Gadag, “Dietary α-lipoic acid supplementation lowers blood pressure in spontaneously hypertensive rats,” Journal of Hypertension, vol. 18, no. 5, pp. 567–573, 2000. View at Publisher · View at Google Scholar · View at Scopus
  106. K. P. Shay, R. F. Moreau, E. J. Smith, A. R. Smith, and T. M. Hagen, “Alpha-lipoic acid as a dietary supplement: molecular mechanisms and therapeutic potential,” Biochimica et Biophysica Acta, vol. 1790, no. 10, pp. 1149–1160, 2009. View at Publisher · View at Google Scholar · View at Scopus
  107. T. J. Kizhakekuttu and M. E. Widlansky, “Natural antioxidants and hypertension: promise and challenges,” Cardiovascular Therapeutics, vol. 28, no. 4, pp. e20–e32, 2010. View at Publisher · View at Google Scholar · View at Scopus
  108. C. J. McMackin, M. E. Widlansky, N. M. Hamburg et al., “Effect of combined treatment with α-Lipoic acid and acetyl-L-carnitine on vascular function and blood pressure in patients with coronary artery disease,” The Journal of Clinical Hypertension, vol. 9, no. 4, pp. 249–255, 2007. View at Publisher · View at Google Scholar · View at Scopus
  109. S. Ozbal, B. U. Ergur, G. Erbil, I. Tekmen, A. Bagryank, and Z. Cavdar, “The effects of α-lipoic acid against testicular ischemia-reperfusion injury in rats,” The Scientific World Journal, vol. 2012, Article ID 489248, 8 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  110. A. Frank, M. Bonney, S. Bonney, L. Weitzel, M. Koeppen, and T. Eckle, “Myocardial ischemia reperfusion injury: from basic science to clinical bedside,” Seminars in Cardiothoracic and Vascular Anesthesia, vol. 16, no. 3, pp. 123–132, 2012. View at Publisher · View at Google Scholar · View at Scopus
  111. E. A. Aiello, R. I. Jabr, and W. C. Cole, “Arrhythmia and delayed recovery of cardiac action potential during reperfusion after ischemia: role of oxygen radical-induced no-reflow phenomenon,” Circulation Research, vol. 77, no. 1, pp. 153–162, 1995. View at Publisher · View at Google Scholar · View at Scopus
  112. M. Dudek, J. Knutelska, M. Bednarski et al., “Alpha lipoic acid protects the heart against myocardial post ischemia-reperfusion arrhythmias via KATP channel activation in isolated rat hearts,” Pharmacological Reports, vol. 66, no. 3, pp. 499–504, 2014. View at Publisher · View at Google Scholar · View at Scopus
  113. C. Deng, Z. Sun, G. Tong et al., “α-Lipoic acid reduces infarct size and preserves cardiac function in rat myocardial ischemia/reperfusion injury through activation of PI3K/Akt/Nrf2 pathway,” PLoS ONE, vol. 8, no. 3, Article ID e58371, 2013. View at Publisher · View at Google Scholar · View at Scopus
  114. Y.-F. Tian, C.-T. He, Y.-T. Chen, and P.-S. Hsieh, “Lipoic acid suppresses portal endotoxemia-induced steatohepatitis and pancreatic inflammation in rats,” World Journal of Gastroenterology, vol. 19, no. 18, pp. 2761–2771, 2013. View at Publisher · View at Google Scholar · View at Scopus
  115. M. Gomes and C. Negrato, “Alpha-lipoic acid as a pleiotropic compound with potential therapeutic use in diabetes and other chronic diseases,” Diabetology & Metabolic Syndrome, vol. 6, article 80, 2014. View at Publisher · View at Google Scholar
  116. M. Bayeva, M. Gheorghiade, and H. Ardehali, “Mitochondria as a therapeutic target in heart failure,” Journal of the American College of Cardiology, vol. 61, no. 6, pp. 599–610, 2013. View at Publisher · View at Google Scholar · View at Scopus
  117. H. Ardehali, H. N. Sabbah, M. A. Burke et al., “Targeting myocardial substrate metabolism in heart failure: potential for new therapies,” European Journal of Heart Failure, vol. 14, no. 2, pp. 120–129, 2012. View at Publisher · View at Google Scholar · View at Scopus
  118. D. B. Sawyer, “Oxidative stress in heart failure: what are we missing?” The American Journal of the Medical Sciences, vol. 342, no. 2, pp. 120–124, 2011. View at Publisher · View at Google Scholar · View at Scopus
  119. C.-J. Li, L. Lv, H. Li, and D.-M. Yu, “Cardiac fibrosis and dysfunction in experimental diabetic cardiomyopathy are ameliorated by alpha-lipoic acid,” Cardiovascular Diabetology, vol. 11, article 73, 2012. View at Publisher · View at Google Scholar · View at Scopus
  120. L. Packer and E. Cadenas, “Lipoic acid: energy metabolism and redox regulation of transcription and cell signaling,” Journal of Clinical Biochemistry and Nutrition, vol. 48, no. 1, pp. 26–32, 2011. View at Publisher · View at Google Scholar · View at Scopus
  121. I. Padmalayam, “Targeting mitochondrial oxidative stress through Lipoic acid synthase: a novel strategy to manage diabetic cardiovascular disease,” Cardiovascular and Hematological Agents in Medicinal Chemistry, vol. 10, no. 3, pp. 223–233, 2012. View at Publisher · View at Google Scholar · View at Scopus
  122. S. Subramanian, B. Kalyanaraman, and R. Q. Migrino, “Mitochondrially targeted antioxidants for the treatment of cardiovascular diseases,” Recent Patents on Cardiovascular Drug Discovery, vol. 5, no. 1, pp. 54–65, 2010. View at Publisher · View at Google Scholar · View at Scopus
  123. C.-J. Li, Q.-M. Zhang, M.-Z. Li, J.-Y. Zhang, P. Yu, and D.-M. Yu, “Attenuation of myocardial apoptosis by alpha-lipoic acid through suppression of mitochondrial oxidative stress to reduce diabetic cardiomyopathy,” Chinese Medical Journal, vol. 122, no. 21, pp. 2580–2586, 2009. View at Publisher · View at Google Scholar · View at Scopus
  124. Z. Cao, M. Tsang, H. Zhao, and Y. Li, “Induction of endogenous antioxidants and phase 2 enzymes by α-lipoic acid in rat cardiac H9C2 cells: protection against oxidative injury,” Biochemical and Biophysical Research Communications, vol. 310, no. 3, pp. 979–985, 2003. View at Publisher · View at Google Scholar · View at Scopus
  125. H. Huk-Kolega, B. Skibska, P. Kleniewska, A. Piechota, Ł. Michalski, and A. Gora̧ca, “Role of lipoic acld in health and disease,” Polski Merkuriusz Lekarski, vol. 31, no. 183, pp. 183–185, 2011. View at Google Scholar · View at Scopus